{"id":7456,"date":"2021-12-16T08:00:33","date_gmt":"2021-12-16T13:00:33","guid":{"rendered":"https:\/\/puyapeptide.net\/product\/lanreotidacetat-cas-127984-74-1-behandling-for-akromegali-og-symptomatiske-neuroendokrine-tumorer\/"},"modified":"2021-12-16T08:00:33","modified_gmt":"2021-12-16T13:00:33","slug":"lanreotidacetat-cas-127984-74-1-behandling-for-akromegali-og-symptomatiske-neuroendokrine-tumorer","status":"publish","type":"product","link":"https:\/\/puyapeptide.net\/da\/product\/lanreotidacetat-cas-127984-74-1-behandling-for-akromegali-og-symptomatiske-neuroendokrine-tumorer\/","title":{"rendered":"Lanreotidacetat CAS 127984-74-1 Behandling for akromegali og symptomatiske neuroendokrine tumorer"},"content":{"rendered":"

Lanreotidacetat CAS 127984-74-1 Behandling for akromegali og symptomatiske neuroendokrine tumorer<\/strong><\/h2>\n

Produktnavn: Lanreotidacetat
\nSynonymer: 10-(4-aminobutyl)-19-[(2-amino-3-naphthalen-2-yl-propanoyl)amino]-N-(1-carbamoyl-2) -hydroxy-propyl)-16-[(4-hydroxyphenyl)methyl]-13-(1H-indol-3-ylmethyl)-6,9,12,15,18-pentaoxo-7-propan-2-yl-1 ,2-dithia-5,8,11,14,17-pentazacycloicosan-4-carboxamid;Somatulina;LANREOTIDACETAT;3-(2-naphthalenyl)-D-alanyl-L-cysteinyl-L-tyrosyl-D-tryptophyl- L-lysyl-L-valyl-L-cysteinyl-L-threoninamid cyklisk (2\u21927)-disulfidacetat; angiopeptinacetat; 10-(4-aminobutyl)-N-(1-amino-3-hydroxy-1-oxobutan -2-yl)-19-[(2-amino-3-naphthalen-2-ylpropanoyl)amino]-16-[(4-hydroxyphenyl)methyl]-13-(1H-indol-3-ylmethyl)-6, 9,12,15,18-pentaoxo-7-propan-2-yl-1,2-dithia-5,8,11,14,17-pentazacycloicosan-4-carboxamid; Lanreotidacetat USP\/EP\/BP
\n CAS: 127984-74-1
\nMF: C54H69N11O10S2
\nMW: 0
\nEINECS:
\nProduktkategorier: Aminosyrer og derivater, l\u00e6gemidler, mellemprodukter og derivater
\nMol fil: 127984-74 1.mol<\/p>\n

Lanreotidacetat, et octapeptid somatostatin analog, n\u00e5ede sit f\u00f8rste verdensomsp\u00e6ndende marked i Frankrig for akromegali, n\u00e5r operation eller str\u00e5lebehandling ikke har form\u00e5et at genoprette normal v\u00e6ksthormonsekretion. Lanreotid er en selektiv h\u00e6mmer af v\u00e6ksthormon og reducerer sekretionen af v\u00e6ksthormon, thyrotropin, motilin og pancreaspolypeptid hos mennesker. Lanreotid har antiproliferative egenskaber og er angiveligt i kliniske fors\u00f8g til forebyggelse af restenose efter koronararterieangioplastik, for diabetisk retinopati og som terapi for psoriasis. Dets potentiale for neuroendokrine tumorer og hormonresponsiv prostatacancer er ogs\u00e5 blevet p\u00e5vist.<\/p>\n

Lanreotide Acetate CAS 127984-74-1 Kemiske egenskaber<\/strong>
\nopbevaringstemperatur. -20\u00b0C
\nform pulver
\nfarve hvid til r\u00e5hvid<\/p>\n

Funktion og anvendelse af Lanreotidacetat CAS 127984-74-1<\/strong>
\nLanreotidacetat, ligesom naturlige v\u00e6ksth\u00e6mmere, er lanreotid en peptidh\u00e6mmer af mange endokrine, neuroendokrine, eksokrine og parakrine funktioner. Lanreotid er mere aktivt og har en l\u00e6ngere virkningsvarighed end naturlige v\u00e6ksth\u00e6mmere. Dets h\u00e6mmende effekt p\u00e5 v\u00e6ksthormonsekretion er v\u00e6sentligt mere selektiv end p\u00e5 insulinsekretion, og i 2017 godkendte FDA lanreotidacetat til injektion til behandling af neuroendokrine tumorer.<\/p>\n","protected":false},"excerpt":{"rendered":"

Produktnavn: Lanreotidacetat
\nCAS: 127984-74-1
\nMF: C54H69N11O10S2
\nMol Fil: 127984-74-1.mol<\/p>\n","protected":false},"featured_media":2098,"comment_status":"open","ping_status":"closed","template":"","meta":{"om_disable_all_campaigns":false,"_monsterinsights_skip_tracking":false,"_monsterinsights_sitenote_active":false,"_monsterinsights_sitenote_note":"","_monsterinsights_sitenote_category":0,"site-sidebar-layout":"default","site-content-layout":"default","ast-site-content-layout":"","site-content-style":"default","site-sidebar-style":"default","ast-global-header-display":"","ast-banner-title-visibility":"","ast-main-header-display":"","ast-hfb-above-header-display":"","ast-hfb-below-header-display":"","ast-hfb-mobile-header-display":"","site-post-title":"","ast-breadcrumbs-content":"","ast-featured-img":"","footer-sml-layout":"","theme-transparent-header-meta":"default","adv-header-id-meta":"","stick-header-meta":"","header-above-stick-meta":"","header-main-stick-meta":"","header-below-stick-meta":"","astra-migrate-meta-layouts":"default","ast-page-background-enabled":"default","ast-page-background-meta":{"desktop":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"ast-content-background-meta":{"desktop":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}}},"product_brand":[],"product_cat":[391],"product_tag":[2305],"class_list":{"0":"post-7456","1":"product","2":"type-product","3":"status-publish","4":"has-post-thumbnail","6":"product_cat-anti-tumor-peptid","7":"product_tag-lanreotide-acetate-cas-127984-74-1-treat-for-acromegaly-and-symptomatic-neuroendocrine-tumors-da","8":"desktop-align-left","9":"tablet-align-left","10":"mobile-align-left","12":"first","13":"instock","14":"shipping-taxable","15":"product-type-simple"},"_links":{"self":[{"href":"https:\/\/puyapeptide.net\/da\/wp-json\/wp\/v2\/product\/7456","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/puyapeptide.net\/da\/wp-json\/wp\/v2\/product"}],"about":[{"href":"https:\/\/puyapeptide.net\/da\/wp-json\/wp\/v2\/types\/product"}],"replies":[{"embeddable":true,"href":"https:\/\/puyapeptide.net\/da\/wp-json\/wp\/v2\/comments?post=7456"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/puyapeptide.net\/da\/wp-json\/wp\/v2\/media\/2098"}],"wp:attachment":[{"href":"https:\/\/puyapeptide.net\/da\/wp-json\/wp\/v2\/media?parent=7456"}],"wp:term":[{"taxonomy":"product_brand","embeddable":true,"href":"https:\/\/puyapeptide.net\/da\/wp-json\/wp\/v2\/product_brand?post=7456"},{"taxonomy":"product_cat","embeddable":true,"href":"https:\/\/puyapeptide.net\/da\/wp-json\/wp\/v2\/product_cat?post=7456"},{"taxonomy":"product_tag","embeddable":true,"href":"https:\/\/puyapeptide.net\/da\/wp-json\/wp\/v2\/product_tag?post=7456"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}